Detailed characterization of the immune response to Epstein-Barr virus in multiple sclerosis and following B cell depleting treatment

preprint OA: closed CC-BY-4.0
📄 Open PDF Full text JSON View at publisher

Abstract

Abstract Aim : To define the viral load and immune response to Epstein-Barr virus (EBV) in multiple sclerosis (MS) and the effect of B cell depleting therapy (BCDT). Methods : The study included healthy controls (HC) and persons with MS (pwMS). EBV viral load was quantified from whole blood DNA. Humoral immune responses were assessed in plasma, and cellular immune responses in peripheral blood mononuclear cells. T cell receptor Vβ (TCRVβ) analysis was performed on sorted blood and cerebrospinal fluid (CSF) cells. Results : EBV viral load did not differ between pwMS and HC. In contrast, distinct differences were found in both humoral and cellular EBV-specific immunity in MS. Antibodies against EBV were increased in pwMS, whereas CD8+ T cell reactivity against lytic antigens, including BZLF1, was reduced. Notably, during periods of disease activity, both CD4+ and CD8+ T cell responses to lytic antigens increased. In addition, BZLF1-specific T cell clones recognizing the peptide RAKFKQLL were the most clonally expanded population in the intrathecal compartment of a pwMS with high CSF T cell counts. BCDT reduced EBV viral load and was coupled to a pronounced reduction in CD8+ T cell responses to all lytic EBV antigens. Conclusion : These findings delineate distinct alterations in EBV-specific immunity in MS and demonstrate that BCDT modulates both viral load and T cell responses. The data support a potential role for CD8+ T cell clones targeting lytic EBV proteins in MS pathogenesis.
Full text 13,624 characters · extracted from preprint-html · click to expand
Detailed characterization of the immune response to Epstein-Barr virus in multiple sclerosis and following B cell depleting treatment | Research Square window.SnipcartSettings = { analytics: { enabled: false } }; (function() { var accessVector = localStorage.getItem('access_vector') || ''; window.dataLayer = window.dataLayer || []; if (accessVector) { window.dataLayer.push({ user: { profile: { profileInfo: { snid: accessVector } } } }); } })(); (function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src='https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);})(window,document,'script','dataLayer','GTM-K279D39R'); Browse Preprints In Review Journals COVID-19 Preprints AJE Video Bytes Research Tools Research Promotion AJE Professional Editing AJE Rubriq About Preprint Platform In Review Editorial Policies Our Team Advisory Board Help Center Sign In Submit a Preprint Cite Share Download PDF Article Detailed characterization of the immune response to Epstein-Barr virus in multiple sclerosis and following B cell depleting treatment Klara Asplund Högelin, Majid Pahlevan Kakhki, Yu Gao, Curtis Cai, and 4 more This is a preprint; it has not been peer reviewed by a journal. https://doi.org/ 10.21203/rs.3.rs-9232525/v1 This work is licensed under a CC BY 4.0 License Status: Under Review Version 1 posted You are reading this latest preprint version Abstract Aim : To define the viral load and immune response to Epstein-Barr virus (EBV) in multiple sclerosis (MS) and the effect of B cell depleting therapy (BCDT). Methods : The study included healthy controls (HC) and persons with MS (pwMS). EBV viral load was quantified from whole blood DNA. Humoral immune responses were assessed in plasma, and cellular immune responses in peripheral blood mononuclear cells. T cell receptor Vβ (TCRVβ) analysis was performed on sorted blood and cerebrospinal fluid (CSF) cells. Results : EBV viral load did not differ between pwMS and HC. In contrast, distinct differences were found in both humoral and cellular EBV-specific immunity in MS. Antibodies against EBV were increased in pwMS, whereas CD8+ T cell reactivity against lytic antigens, including BZLF1, was reduced. Notably, during periods of disease activity, both CD4+ and CD8+ T cell responses to lytic antigens increased. In addition, BZLF1-specific T cell clones recognizing the peptide RAKFKQLL were the most clonally expanded population in the intrathecal compartment of a pwMS with high CSF T cell counts. BCDT reduced EBV viral load and was coupled to a pronounced reduction in CD8+ T cell responses to all lytic EBV antigens. Conclusion : These findings delineate distinct alterations in EBV-specific immunity in MS and demonstrate that BCDT modulates both viral load and T cell responses. The data support a potential role for CD8+ T cell clones targeting lytic EBV proteins in MS pathogenesis. Biological sciences/Immunology/Adaptive immunity Biological sciences/Neuroscience/Diseases of the nervous system/Multiple sclerosis Multiple sclerosis Epstein-Barr virus humoral immunity cellular immunity B cell depletion Full Text Additional Declarations There is NO Competing Interest. Cite Share Download PDF Status: Under Review Version 1 posted You are reading this latest preprint version Research Square lets you share your work early, gain feedback from the community, and start making changes to your manuscript prior to peer review in a journal. As a division of Research Square Company, we’re committed to making research communication faster, fairer, and more useful. We do this by developing innovative software and high quality services for the global research community. Our growing team is made up of researchers and industry professionals working together to solve the most critical problems facing scientific publishing. Also discoverable on Platform About Our Team In Review Editorial Policies Advisory Board Help Center Resources Author Services Accessibility API Access RSS feed Manage Cookie Preferences © Research Square 2026 | ISSN 2693-5015 (online) Privacy Policy Terms of Service Do Not Sell My Personal Information {"props":{"pageProps":{"initialData":{"identity":"rs-9232525","acceptedTermsAndConditions":true,"allowDirectSubmit":false,"archivedVersions":[],"articleType":"Article","associatedPublications":[],"authors":[{"id":615925505,"identity":"9ba54f04-cc34-4be6-8db5-12ef752e617c","order_by":0,"name":"Klara Asplund Högelin","email":"data:image/png;base64,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","orcid":"","institution":"Karolinska Institutet","correspondingAuthor":true,"prefix":"","firstName":"Klara","middleName":"Asplund","lastName":"Högelin","suffix":""},{"id":615925506,"identity":"1eae9d57-80e9-4094-bf0c-11fa52c62c9b","order_by":1,"name":"Majid Pahlevan Kakhki","email":"","orcid":"https://orcid.org/0000-0002-5407-3147","institution":"Karolinska Institutet","correspondingAuthor":false,"prefix":"","firstName":"Majid","middleName":"Pahlevan","lastName":"Kakhki","suffix":""},{"id":615925507,"identity":"12601f68-e902-463a-8a54-0127777dba40","order_by":2,"name":"Yu Gao","email":"","orcid":"","institution":"Karolinska Institute","correspondingAuthor":false,"prefix":"","firstName":"Yu","middleName":"","lastName":"Gao","suffix":""},{"id":615925508,"identity":"1712d245-0a8e-49a4-b73d-2b289ddc16ae","order_by":3,"name":"Curtis Cai","email":"","orcid":"https://orcid.org/0000-0002-3490-4361","institution":"Karolinska Institutet","correspondingAuthor":false,"prefix":"","firstName":"Curtis","middleName":"","lastName":"Cai","suffix":""},{"id":615925509,"identity":"3cb78cfa-51d4-4bf6-abbe-f4e0a65a753e","order_by":4,"name":"Lucille Margerie","email":"","orcid":"https://orcid.org/0000-0001-9537-1231","institution":"Karolinska Institutet","correspondingAuthor":false,"prefix":"","firstName":"Lucille","middleName":"","lastName":"Margerie","suffix":""},{"id":615925510,"identity":"501c4183-5695-4980-ba17-40b06ba8bab0","order_by":5,"name":"Mohsen Khademi","email":"","orcid":"https://orcid.org/0000-0003-0801-1444","institution":"Karolinska Institute","correspondingAuthor":false,"prefix":"","firstName":"Mohsen","middleName":"","lastName":"Khademi","suffix":""},{"id":615925511,"identity":"a7dcf85f-7659-43e7-835a-4e4460ec08f7","order_by":6,"name":"Marcus Buggert","email":"","orcid":"https://orcid.org/0000-0003-0633-1719","institution":"Karolinska","correspondingAuthor":false,"prefix":"","firstName":"Marcus","middleName":"","lastName":"Buggert","suffix":""},{"id":615925512,"identity":"00afc15b-14d9-4e97-8db8-1041375d83ae","order_by":7,"name":"Faiez Al Nimer","email":"","orcid":"","institution":"Karolinska Institutet","correspondingAuthor":false,"prefix":"","firstName":"Faiez","middleName":"Al","lastName":"Nimer","suffix":""}],"badges":[],"createdAt":"2026-03-26 10:02:04","currentVersionCode":1,"declarations":"","doi":"10.21203/rs.3.rs-9232525/v1","doiUrl":"https://doi.org/10.21203/rs.3.rs-9232525/v1","draftVersion":[],"editorialEvents":[],"editorialNote":"","failedWorkflow":false,"files":[{"id":106093562,"identity":"72decbe4-436f-4eb2-ab6d-21aa088b46e9","added_by":"auto","created_at":"2026-04-03 11:38:06","extension":"pdf","order_by":1,"title":"","display":"","copyAsset":false,"role":"manuscript-pdf","size":2194941,"visible":true,"origin":"","legend":"Article File","description":"","filename":"ManuscriptEBVarticle.pdf","url":"https://assets-eu.researchsquare.com/files/rs-9232525/v1_covered_1d064300-41e4-4c24-b515-ff364bbb3555.pdf"}],"financialInterests":"There is \u003cb\u003eNO\u003c/b\u003e Competing Interest.","formattedTitle":"Detailed characterization of the immune response to Epstein-Barr virus in multiple sclerosis and following B cell depleting treatment","fulltext":[],"fulltextSource":"","fullText":"","funders":[],"hasAdminPriorityOnWorkflow":false,"hasManuscriptDocX":false,"hasOptedInToPreprint":true,"hasPassedJournalQc":"","hasAnyPriority":true,"hideJournal":false,"highlight":"","institution":"","isAcceptedByJournal":false,"isAuthorSuppliedPdf":true,"isDeskRejected":"","isHiddenFromSearch":false,"isInQc":false,"isInWorkflow":false,"isPdf":true,"isPdfUpToDate":true,"isWithdrawnOrRetracted":false,"journal":{"display":true,"email":"[email protected]","identity":"nature-portfolio","isNatureJournal":true,"hasQc":false,"allowDirectSubmit":false,"externalIdentity":"","sideBox":"","snPcode":"","submissionUrl":"","title":"Nature Portfolio","twitterHandle":"","acdcEnabled":false,"dfaEnabled":false,"editorialSystem":"ejp","reportingPortfolio":"","inReviewEnabled":true,"inReviewRevisionsEnabled":false},"keywords":"Multiple sclerosis, Epstein-Barr virus, humoral immunity, cellular immunity, B cell depletion","lastPublishedDoi":"10.21203/rs.3.rs-9232525/v1","lastPublishedDoiUrl":"https://doi.org/10.21203/rs.3.rs-9232525/v1","license":{"name":"CC BY 4.0","url":"https://creativecommons.org/licenses/by/4.0/"},"manuscriptAbstract":"\u003cp\u003e\u003cstrong\u003eAim\u003c/strong\u003e: To define the viral load and immune response to Epstein-Barr virus (EBV) in multiple sclerosis (MS) and the effect of B cell depleting therapy (BCDT).\u0026nbsp;\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eMethods\u003c/strong\u003e: The study included healthy controls (HC) and persons with MS (pwMS). EBV viral load was quantified from whole blood DNA. Humoral immune responses were assessed in plasma, and cellular immune responses in peripheral blood mononuclear cells. T cell receptor Vβ (TCRVβ) analysis was performed on sorted blood and cerebrospinal fluid (CSF) cells.\u0026nbsp;\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eResults\u003c/strong\u003e: EBV viral load did not differ between pwMS and HC. In contrast, distinct differences were found in both humoral and cellular EBV-specific immunity in MS. Antibodies against EBV were increased in pwMS, whereas CD8+ T cell reactivity against lytic antigens, including BZLF1, was reduced. Notably, during periods of disease activity, both CD4+ and CD8+ T cell responses to lytic antigens increased. In addition, BZLF1-specific T cell clones recognizing the peptide RAKFKQLL were the most clonally expanded population in the intrathecal compartment of a pwMS with high CSF T cell counts. BCDT reduced EBV viral load and was coupled to a pronounced reduction in CD8+ T cell responses to all lytic EBV antigens.\u0026nbsp;\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eConclusion\u003c/strong\u003e: These findings delineate distinct alterations in EBV-specific immunity in MS and demonstrate that BCDT modulates both viral load and T cell responses. The data support a potential role for CD8+ T cell clones targeting lytic EBV proteins in MS pathogenesis.\u003c/p\u003e","manuscriptTitle":"Detailed characterization of the immune response to Epstein-Barr virus in multiple sclerosis and following B cell depleting treatment","msid":"","msnumber":"","nonDraftVersions":[{"code":1,"date":"2026-04-02 03:34:04","doi":"10.21203/rs.3.rs-9232525/v1","editorialEvents":[],"status":"published","journal":{"display":true,"email":"[email protected]","identity":"nature-communications","isNatureJournal":true,"hasQc":false,"allowDirectSubmit":false,"externalIdentity":"NCOMMS","sideBox":"Learn more about [Nature Communications](http://www.nature.com/ncomms/)","snPcode":"","submissionUrl":"https://mts-ncomms.nature.com/","title":"Nature Communications","twitterHandle":"","acdcEnabled":true,"dfaEnabled":true,"editorialSystem":"ejp","reportingPortfolio":"Nature Communications","inReviewEnabled":true,"inReviewRevisionsEnabled":false}}],"origin":"","ownerIdentity":"141c138c-30fc-4966-b0f3-c424936b963e","owner":[],"postedDate":"April 2nd, 2026","published":true,"recentEditorialEvents":[{"type":"editorInvitedReview","content":"This content is not available.","date":"2026-05-06T07:35:36+00:00","index":2,"fulltext":"This content is not available."},{"type":"editorInvitedReview","content":"This content is not available.","date":"2026-05-05T09:32:06+00:00","index":1,"fulltext":"This content is not available."},{"type":"editorInvitedReview","content":"This content is not available.","date":"2026-05-03T11:50:02+00:00","index":3,"fulltext":"This content is not available."}],"rejectedJournal":[],"revision":"","amendment":"","status":"under-review","subjectAreas":[{"id":65543228,"name":"Biological sciences/Immunology/Adaptive immunity"},{"id":65543229,"name":"Biological sciences/Neuroscience/Diseases of the nervous system/Multiple sclerosis"}],"tags":[],"updatedAt":"2026-04-02T03:34:04+00:00","versionOfRecord":[],"versionCreatedAt":"2026-04-02 03:34:04","video":"","vorDoi":"","vorDoiUrl":"","workflowStages":[]},"version":"v1","identity":"rs-9232525","journalConfig":"researchsquare"},"__N_SSP":true},"page":"/article/[identity]/[[...version]]","query":{"redirect":"/article/rs-9232525","identity":"rs-9232525","version":["v1"]},"buildId":"XKTyCvWXoU3ODBz1xrDgd","isFallback":false,"isExperimentalCompile":false,"dynamicIds":[84888],"gssp":true,"scriptLoader":[]}

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: preprint-html

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2026) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

Source provenance

europepmc
last seen: 2026-05-20T01:45:00.602351+00:00
unpaywall
last seen: 2026-05-26T02:00:01.498150+00:00
License: CC-BY-4.0